Exyte continues excellent business performance in the third quarter of 2019

- Sales increases year on year by 6.5% in the first nine months of 2019

- Profitability significantly improved; adjusted EBIT up 33.3% year on year

- Exyte about to close an excellent financial year

Stuttgart, 13 November 2019 - Exyte AG ("Exyte"), a global leader in the design, engineering and construction of high-tech facilities, plants and factories, is set to continue on its growth path after a successful third quarter. Sales and profitability improved significantly compared to Q3 2018, thereby continuing the positive trend from the first half of the year. Exyte expects record sales in the magnitude of around EUR 4.0 billion in financial year 2019 (2018: EUR 3.5 billion).

In the first nine months of 2019, Exyte generated sales of EUR 2.7 billion (9M 2018: EUR 2.6 billion) and an adjusted EBIT of EUR 148 million (9M 2018: EUR 111 million). The company therefore continued sales growth and noticeably boosted profitability year on year. Sales was 6.5% higher than in the first nine months of financial year 2018, and adjusted EBIT improved by 33.3%. The adjusted EBIT margin increased to 5.4% (9M 2018: 4.3%).

Dr. Wolfgang Büchele, CEO of Exyte, said: "We have carried on the momentum from the positive first half of the year and are delighted with the successful business development in the third quarter. We are certain that the financial year 2019 is set to be an excellent year for our company. All of our expectations have been met." In all, Exyte recorded order intake of EUR 3.6 billion in the first nine months of this financial year (9M 2018: EUR 3.5 billion), which is an increase of almost 4% year on year. Dr. Büchele explains: "Last year saw us receive an extraordinary project in the APAC region, which was expectedly not repeated in 2019. Nevertheless, we were able to more than compensate for this with an increase in orders in the other two regions". These included projects in Denmark (Data Center), Ireland, Israel and Austria (semiconductors), to name a few. With EUR 1.2 billion, Exyte more than doubled its order intake in the third quarter alone compared to Q3 2018 (EUR 519 million). As of 30 September 2019, Exyte's order book was solid, with an order backlog totalling EUR 3.8 billion (9M 2018: EUR 3.0 billion).

ATF remains the strongest business segment; DTC records considerable growth

Exyte was able to continue to grow in its largest business segment, Advanced Technology Facilities (ATF; esp. semiconductors), in the third quarter as well. At EUR 2.2 billion, Exyte increased sales in this business segment by 12.1% year on year in the first nine months of the current financial year, primarily driven by projects in Singapore, Ireland, the US, Austria and Malaysia (9M 2018: EUR 2.0 billion). At the same time, sales in the smaller strategic business segment Data Center increased noticeably from EUR 136 million in the previous-year period to EUR 197 million in the first nine months of financial year 2019 (+44.9%). Sales in the Life Sciences & Chemicals (LSC) business segment remained virtually unchanged year on year at EUR 240 million (9M 2018: EUR 245 million).

With sales of EUR 1.3 billion, the Asia-Pacific (APAC) region is still Exyte's largest regional market, although the figure was marginally below the level of the previous year (9M 2018: EUR 1.4 billion). However, Exyte was able to considerably increase the sales in Europe (EMEA) in the first nine months of financial year 2019. In the EMEA region, Exyte generated sales of EUR 944 million in the current period, which is a year-on-year increase of 43.2% (9M 2018: EUR 659 million). Sales in the Americas region (AMER) was slightly down on the previous year at EUR 402 million (9M 2018: EUR 452 million). Based on the healthy order intake, the company expects a positive development in this market as well in the future.

Exyte about to close an excellent year

"We believe we will be able to continue this positive trend in 2020 as well and grow further. We will continue to build on our strong market position and our innovative solutions, which are highly appreciated by our customers," Dr. Büchele explains.

Exyte confirms its sales forecast for this financial year in the magnitude of around EUR 4.0 billion (2018: EUR 3.5 billion). At the same time, Exyte expects order intake to stay at the level of the previous year (2018: EUR 4.4 billion) and anticipates a moderate increase of the adjusted EBIT (2018: EUR 170 million). The company believes it can continue to grow in financial year 2020 and aims for sales of EUR 5 billion in the medium term and for an adjusted EBIT margin of >= 5%.

For more information, see .

About Exyte

Exyte is a global leader in the design, engineering and delivery of facilities for high-tech industries. With a history of more than 100 years, the company has developed a unique expertise in controlled and regulated environments. Exyte has a truly global footprint, serving the most technically demanding clients in markets such as semiconductors, batteries, pharmaceuticals, biotechnology, and data centers. The company offers a full range of services from consulting to the managing of turnkey solutions - delivered to the highest quality and safety standards. Solving the most complex challenges, Exyte forges trusted, long-lasting relationships with its clients. In 2018, Exyte generated sales of EUR 3.5 billion with over 5,600 highly experienced and motivated employees. The company is ideally positioned to further strengthen its market leadership with its broad industry insight and its exceptional talents.